thyroid cancer Veracyte Q2 Revenues More Than Double on Test Volume Spike The company's commercial test volume and test revenues were both up more than 200 percent compared to the same quarter last year. PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more. Genomic Effects of Radiation From Chernobyl Nuclear Disaster Examined in New Studies The studies examined mutational effects of ionizing radiation in exposed children who developed thyroid cancer and in offspring of exposed parents. Bayer, Veracyte to Identify Therapy-Resistant Thyroid Cancer Patients Bayer will offer Veracyte's Afirma Xpression Atlas to identify underlying drivers in tumors of late-stage or metastatic thyroid cancer patients resistant to radioactive iodine therapy. Jun 9, 2020 NeoGenomics, Lilly Oncology Partner for Thyroid Cancer Testing Program Jun 5, 2020 Secondary Tumor Risk in Pediatric Cancer Survivors Linked to Germline Variants, Treatment Type Apr 21, 2020 ArcherDx, Premier Collaborate to Evaluate Genomic Sequencing Assay for Cancers Jan 31, 2020 Chilean Startup GeneproDx Developing Molecular Test to Determine Thyroid Cancer Risk Premium Dec 20, 2019 Interpace Biosciences Expanding Beyond Dx, Cancer With Acquisition, Name Change Premium Dec 19, 2019 Guardant Health Liquid Biopsy Test Gets Expanded Medicare Coverage for Solid Tumors Dec 2, 2019 Genetron Health Gets China NMPA Approval for Clinical NGS System, Files for IPO Nov 13, 2019 Interpace Diagnostics Reports 33 Percent Q3 Revenue Growth; Changes Name to Interpace Biosciences Nov 5, 2019 Sonic Healthcare Expands Deal for UPMC's ThyroSeq Thyroid Cancer Test Sep 30, 2019 Interpace Diagnostics Signs Thyroid Cancer Test Coverage Deals With Three BCBS Plans Sep 9, 2019 Thermo Fisher Scientific, Eli Lilly to Develop CDx for RET Inhibitor Aug 13, 2019 Interpace Diagnostics Q2 Revenues Climb 14 Percent Jul 31, 2019 Interpace Diagnostics Thyroid Tests Covered In-Network by BCBS of Michigan Jul 29, 2019 Interpace Diagnostics Thyroid Assays Covered In-Network by Blue Shield of California Jul 22, 2019 Interpace Diagnostics, SelectHealth Sign Coverage Agreement for Thyroid Cancer Tests Jul 18, 2019 Helomics Inks Separate Pacts With UPMC, Interpace Dx for AI-Driven Oncology Decision Making Jun 20, 2019 Interpace Diagnostics Thyroid Assays Covered by Independence Blue Cross May 13, 2019 Interpace Diagnostics Q1 Revenues Rise 25 Percent May 8, 2019 Study Demonstrates Genomics Impact in Healthy People, Inspires New Commercial Spinout Premium Apr 23, 2019 Interpace Diagnostics Receives Approval to Launch Thyroid Test in New York Load More Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.